--- title: "Pre-market hot trades in US stocks: Micron Tech up 3.64% pre-market; Intel up 3.59% pre-market" type: "News" locale: "en" url: "https://longbridge.com/en/news/286774695.md" description: "Micron Tech pre-market rose 3.64%; Intel pre-market rose 3.59%; Sunshine Biopharma pre-market rose 526.50%; GeoVax Labs pre-market rose 143.01%; Virax Biolabs pre-market rose 125.80%" datetime: "2026-05-18T12:57:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286774695.md) - [en](https://longbridge.com/en/news/286774695.md) - [zh-HK](https://longbridge.com/zh-HK/news/286774695.md) --- # Pre-market hot trades in US stocks: Micron Tech up 3.64% pre-market; Intel up 3.59% pre-market **Pre-market Hot Trades in US Stocks** Micron Technology is up 3.64% in pre-market trading. Based on recent key news: 1. On May 17, Micron Technology projected earnings of nearly $100 billion over the next 12 months, surpassing Meta and Berkshire Hathaway, driving the stock price up. Analysts are optimistic about its earnings prospects, believing it will become the sixth highest-earning publicly traded company in the U.S. Source: Investing.com 2. On May 15, Samsung Electronics entered emergency management mode, planning to strike affecting DRAM production, which may lead to a tightening of market supply, and Micron Technology is expected to benefit from this. Source: Mizuho Technology 3. On May 15, Applied Materials released a strong earnings report, showing a surge in demand for AI computing and storage chips, prompting Micron Technology and other clients to expand production capacity. Source: Applied Materials statement on strong semiconductor industry demand and increasing geopolitical risks. Intel is up 3.59% in pre-market trading. Based on recent key news: 1. On May 18, U.S. President Donald Trump stated in an interview with Fortune magazine that he should have demanded a larger stake in Intel. Trump claimed that the U.S. government exchanged about $10 billion in chip subsidies and investments in plant construction or expansion for a 10% stake in Intel, which has since risen to over $50 billion. This news boosted market confidence in Intel, driving the stock price up. 2. On May 18, Citigroup raised Intel's target stock price from $95 to $130. Citigroup noted that Intel's data center sales have increased, and its ASIC business, including the Mount Evans IPU, may provide more upside potential. Analysts' optimistic expectations further drove the stock price up. 3. On May 16, Intel reached a preliminary agreement with Apple to produce some chips for Apple devices. This news reversed the separation between the two companies that had lasted for years, enhancing market confidence in Intel's manufacturing business and driving the stock price up. Strong demand for AI and an optimistic industry outlook. **Top Gainers in Pre-market US Stocks** Sunshine Biopharma is up 526.50% in pre-market trading, with no significant recent news. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. GeoVax Labs is up 143% in pre-market trading. Based on recent key news: 1. On May 14, GeoVax Labs released a document through the SEC regarding its strategic focus, emphasizing prioritizing capital and operations on the GEO-MVA project while maintaining Gedeptin development as an important long-term option in the combination immunotherapy. This strategic adjustment was seen as a positive signal by the market, driving the stock price significantly up. 2. On May 14, GeoVax Labs published original content on the EDGAR system, detailing its strategic direction and capital allocation plans The market expresses optimism about the clarity of the company's future development direction, further stimulating the rise in stock prices. On May 14th, the strategic adjustment of GeoVax Labs was seen as a positive boost to the company's long-term growth potential, with investors expressing confidence in its potential in the field of combination immunotherapy, leading to a significant increase in stock prices. The biotechnology industry has performed strongly recently, with noticeable capital inflows. Virax Biolabs, pre-market up 125.80%, has had no significant news recently. Trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation ### Related Stocks - [MU.US](https://longbridge.com/en/quote/MU.US.md) - [INTC.US](https://longbridge.com/en/quote/INTC.US.md) - [SBFM.US](https://longbridge.com/en/quote/SBFM.US.md) - [GOVX.US](https://longbridge.com/en/quote/GOVX.US.md) - [VRAX.US](https://longbridge.com/en/quote/VRAX.US.md) ## Related News & Research - [Tiger Global’s $180M Intel bet fuels AI-era optimism](https://longbridge.com/en/news/286868190.md) - [Intel's AI Comeback: CEO Reveals Insatiable CPU Demand As Customers Bulk Up Orders](https://longbridge.com/en/news/286895882.md) - [If You Invested $100 In Intel Stock 5 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/286441099.md) - [Intel hits record high as Tiger Global invests $180M](https://longbridge.com/en/news/286681794.md) - [Intel stock analysis shows beyond the fact that it was up yesterday, and not for long](https://longbridge.com/en/news/286392189.md)